Tags

Type your tag names separated by a space and hit enter

[Managing the attacks, preventing headache. Migraine therapy in 2002].
MMW Fortschr Med. 2002 May 06; Suppl 2:43-50.MF

Abstract

At the heart of every migraine treatment concept is the management of the acute attack with effective medication. Here, the triptans have been progressively replacing the ergot alkaloids with their unsatisfactory relationship between effect and side effects. Prophylactic medication is indicated when, despite every non-pharmaceutic measure, migraine attacks occur on seven or more days in a month. The beta receptor blockers metoprolol and propranolol have so far been considered the substances of first choice, but in practice there is now a trend towards substances with a lower potential for side effects. The article provides an up-to-date overview of the efficacy and tolerability of the various migraine prophylactics.

Authors+Show Affiliations

Neurologisch-verhaltensmedizinische Schmerzklinik Kiel. Kiel@Schmerzklinik.deNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
English Abstract
Journal Article

Language

ger

PubMed ID

12070849

Citation

Göbel, H, et al. "[Managing the Attacks, Preventing Headache. Migraine Therapy in 2002]." MMW Fortschritte Der Medizin, vol. Suppl 2, 2002, pp. 43-50.
Göbel H, Heinze A, Heinze-Kuhn K. [Managing the attacks, preventing headache. Migraine therapy in 2002]. MMW Fortschr Med. 2002;Suppl 2:43-50.
Göbel, H., Heinze, A., & Heinze-Kuhn, K. (2002). [Managing the attacks, preventing headache. Migraine therapy in 2002]. MMW Fortschritte Der Medizin, Suppl 2, 43-50.
Göbel H, Heinze A, Heinze-Kuhn K. [Managing the Attacks, Preventing Headache. Migraine Therapy in 2002]. MMW Fortschr Med. 2002 May 6;Suppl 2:43-50. PubMed PMID: 12070849.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Managing the attacks, preventing headache. Migraine therapy in 2002]. AU - Göbel,H, AU - Heinze,A, AU - Heinze-Kuhn,K, PY - 2002/6/20/pubmed PY - 2002/9/11/medline PY - 2002/6/20/entrez SP - 43 EP - 50 JF - MMW Fortschritte der Medizin JO - MMW Fortschr Med VL - Suppl 2 N2 - At the heart of every migraine treatment concept is the management of the acute attack with effective medication. Here, the triptans have been progressively replacing the ergot alkaloids with their unsatisfactory relationship between effect and side effects. Prophylactic medication is indicated when, despite every non-pharmaceutic measure, migraine attacks occur on seven or more days in a month. The beta receptor blockers metoprolol and propranolol have so far been considered the substances of first choice, but in practice there is now a trend towards substances with a lower potential for side effects. The article provides an up-to-date overview of the efficacy and tolerability of the various migraine prophylactics. SN - 1438-3276 UR - https://www.unboundmedicine.com/medline/citation/12070849/[Managing_the_attacks_preventing_headache__Migraine_therapy_in_2002]_ L2 - http://www.diseaseinfosearch.org/result/4811 DB - PRIME DP - Unbound Medicine ER -